Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

CLSA noted that when the RBI gave a one-year extension to the MD of RBL Bank, and later appointed a PSU banker, the stock ...

The stock, which recorded a steep 27 per cent on Tuesday post its internal review, traded almost flat on Thursday. Last ...

An analyst from StoxBox said that Yes Bank struggles to hold key support levels and lacks clear directional momentum. The RSI ...

The stock market experienced declines on March 12, with Dr. Reddy's Laboratories and others reaching yearly lows due to US ...

The IndusInd Bank share price today, March 12, 2025, has indicated a recovery. As of 11.39 am, the shares are trading at ₹675 ...

The stock surged nearly 14% from its intraday low, climbing to Rs 690 on the National Stock Exchange (NSE), breaking a ...

Promoter of IndusInd Bank, Ashok Hinduja has assured that the lender's financials remain healthy, and it will be fully ...

Despite recent setbacks, IndusInd Bank remains financially stable, with little reason for depositors to worry. The reported ...

Trent, Sun Pharma, ICICI Bank, Shriram Finance, BPCL were among the top gainers on the Nifty, while losers were IndusInd Bank ...

Bank deputy CEO Arun Khurana said the discrepancies are not linked to client accounts. Experts, however, stated the internal ...

IndusInd Bank share came under heavy selling pressure on Tuesday after a massive discrepancy in the private bank's derivative ...